Epizyme A Buy On Firmer Tazemetostat Timeline [Seeking Alpha]
Epizyme, Inc. (EPZM)
Last epizyme, inc. earnings: 2/24 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
epizyme.com
Company Research
Source: Seeking Alpha
Epizyme A Buy On Firmer Tazemetostat Timeline Summary Tazemetostat for epithelioid sarcoma NDA submitted to FDA on May 30. Phase 2 data looks good. Label expansion could be ahead as well. Epizyme ( EPZM Epizyme appears to be near that goal. Epizyme submitted The news was a slight positive for the stock, which has been wildly volatile in the past year, like many pharmaceutical company stocks. On May 29, it closed at $13.65. It closed at $13.74 on May 31. The submission of the NDA was expected, only the timing was uncertain. The 52-week low for the past year had been $5.14, while the 52-week high has been $17.35. I am setting my new target for Epizyme at the 52-week high, which would be up 26% from its close on May 31. I believe the firmer timeline for an up-or-down decision on the first Tazemetostat indication makes Epizyme a good buy at the recent price. Tazemetostat and epithelioid sarcoma Tazemetostat inhibits EZH2, an enzyme that participates in histone methylation, which determine
Show less
Read more
Impact Snapshot
Event Time:
EPZM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EPZM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EPZM alerts
High impacting Epizyme, Inc. news events
Weekly update
A roundup of the hottest topics